Search

everythinglearnresearchcommunity

for

Search:↓

Estrogen is important for keeping adult mouse nipple skin healthy by controlling certain cell signals.

Some cancer treatments can cause permanent hair loss.

Hair health depends on various factors and hair loss can significantly affect a person's well-being; understanding hair biology is key for creating effective hair care treatments.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Some horses lose hair without inflammation or itching due to various conditions, and while mainly a cosmetic issue, diagnosis requires examination and biopsies, and breeding is not advised if it's hereditary.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Vitamin D3 is important for hair growth and protecting skin from damage caused by long-term sun exposure.

A woman showed neurological symptoms from psittacosis linked to bird exposure, improving after antibiotic treatment.

Safflower oil nanoparticles can deliver hFGF10 to hair follicles, reduce inflammation, and potentially speed up hair growth in conditions causing hair loss.

Millet and wheat extracts may improve hair health and promote growth.

Hair can regrow in large wounds through a process similar to how hair forms in embryos, and understanding this could lead to new treatments for hair loss or scarring.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

Some cases of folliculotropic mycosis fungoides may progress slowly and not need aggressive treatment.

Ingenol mebutate gel changes gene expression related to skin development and immune response in actinic keratosis.

We need better treatments for hair loss, and while test-tube methods are helpful, they can't fully replace animal tests for evaluating new hair growth treatments.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Overexpressing thrombospondin-1 in mice skin prevents UVB-induced skin damage.

Hair follicle stem cells are key for hair and skin regeneration, can be reprogrammed, and have potential therapeutic uses, but also carry a risk of cancer.

Ablative fractional resurfacing could improve how well topical drugs penetrate the skin, but more research is needed to fine-tune the method.

Bioengineering can potentially treat hair loss by regenerating hair follicles and cloning hair, but the process is complex and needs more research.

Home-use lasers and IPL devices are unlikely to directly cause paradoxical hair growth; it may be linked to inflammation or hormonal issues.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Oxidative stress damages hair and contributes to aging, and managing it can help maintain hair health.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

Multiphoton microscopy can non-invasively tell apart scarring from non-scarring hair loss and could aid in treatment.

Activating TRPV4 in skin cells helps regrow hair in mice, possibly offering a treatment for hair loss.

The cosmetic industry should adapt to the varied beauty standards of ethnic groups and offer specialized treatments.

The conclusion is that CD90 is not a specific marker for fibroblast subtypes and better methods are needed to identify them.